期刊
MOLECULAR ONCOLOGY
卷 16, 期 9, 页码 1931-1946出版社
WILEY
DOI: 10.1002/1878-0261.12946
关键词
cutaneous T-cell lymphomas; DNA methylation; DNMTi; HDACi; telomerase; TERT
类别
资金
- National Institute of Health and Medical Research (INSERM)
- French Society of Dermatology (SFD)
- Ligue Regionale contre le Cancer
- Hubert Curien Partnership (PHC-CEDRE)
- ERASMUS+
- Hubert Curien Partnership (PHC-PESSOA)
- Ligue Nationale contre le Cancer
- National Center for Scientific Research (CNRS)
The study found a specific methylation pattern in the hTERT promoter region in cutaneous T-cell lymphoma (CTCL) cells, matching with the TERT HyperMethylated Oncogenic Region (THOR), which remains relatively stable under approved epigenetic drugs for CTCL treatment, contrary to the expected impact of reducing hTERT gene expression.
Cutaneous T-cell lymphomas (CTCLs) are telomerase-positive tumors expressing hTERT, although neither gene rearrangement/amplification nor promoter hotspot mutations could explain the hTERT re-expression. As the hTERT promoter is rich in CpG, we investigated the contribution of epigenetic mechanisms in its re-expression. We analyzed hTERT promoter methylation status in CTCL cells compared with healthy cells. Gene-specific methylation analyses revealed a common methylation pattern exclusively in tumor cells. This methylation pattern encompassed a hypermethylated distal region from -650 to -150 bp and a hypomethylated proximal region from -150 to +150 bp. Interestingly, the hypermethylated region matches with the recently named TERT hypermethylated oncogenic region (THOR). THOR has been associated with telomerase reactivation in many cancers, but it has so far not been reported in cutaneous lymphomas. Additionally, we assessed the effect of THOR on two histone deacetylase inhibitors (HDACi), romidepsin and vorinostat, both approved for CTCL treatment and a DNA methyltransferase inhibitor (DNMTi) 5-azacytidine, unapproved for CTCL. Contrary to our expectations, the findings reported herein revealed that THOR methylation is relatively stable under these epigenetic drugs' pressure, whereas these drugs reduced the hTERT gene expression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据